AM Best Upgrades Credit Ratings of Somerset Reinsurance Ltd. and Somerset Reinsurance Company
The ratings of Somerset Re reflect the company's balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management (ERM).
The ratings of SRC reflect the company's balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, neutral business profile and appropriate ERM.
Somerset Re and SRC are focused on providing reinsurance solutions for asset-intensive life insurance and annuity business, including programs for new business flow and management of legacy blocks of life insurance and annuities.
The rating upgrades reflect Somerset Re's ability to execute on its business plan, including positive core earnings trends in profitability and premium growth and also reflect SRC's support of the overall business plan.
Somerset Re's risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio (BCAR), is expected to remain at the strongest level. Liquidity is assessed as more than adequate to fund anticipated short-term obligations of the current blocks of business held on the company's balance sheet.
Furthermore, Somerset Re continues to enhance its position in its markets of operation as it continues to execute reinsurance agreements each year with known rated insurers in line with the company's business plan. Experience-related metrics are showing strong evidence of prudent pricing and investment management discipline.
AM Best anticipates capital infusions to continue that will support further new business growth over the intermediate term without the need to access additional funding.
The companies are backed by a very experienced reinsurance management team with deep ties to the industry. The ERM programs are well-developed and currently appropriate for the companies' business operations.
This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.
Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250731809267/en/
Contacts
Stephen Vincent Associate Director +1 908 882 1705 stephen.vincent@ambest.com
Edward Kohlberg Director +1 908 882 1979 edward.kohlberg@ambest.com
Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 christopher.sharkey@ambest.com
Al Slavin Senior Public Relations Specialist +1 908 882 2318 al.slavin@ambest.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
PRINCETON, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. ('ANI' or the 'Company') (NASDAQ: ANIP) today announced that the Company will release its second quarter 2025 financial results on Friday, August 8, 2025, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, Chris Mutz, Head of Rare Disease, and Mary Pao, M.D., Ph.D., Chief Medical Officer, will host a conference call to discuss the results as follows: Date Friday, August 8, 2025 Time 8:30 a.m. ET Toll free (U.S.) 800-343-4136 Conference ID 5034065 Webcast (live and replay) under the 'Investors' section A replay of the conference call will be available within two hours of the call's completion and will remain accessible for two weeks by dialing 800-839-6803 and entering access code 5034065. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of 'Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit Investor Relations Contact:Lisa M. Wilson, In-Site Communications, Inc.212-452-2793lwilson@ SOURCE: ANI Pharmaceuticals, Inc.
Yahoo
13 minutes ago
- Yahoo
Chromatography Resin Market worth $4.94 billion by 2030 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 1, 2025 /PRNewswire/ -- The report "Chromatography Resin Market by Type (Natural, Synthetic, Inorganic Media), Technique ((Ion Exchange (Cation and Anion), Affinity (Hydrophobic Interaction, Mixed Mode)), Application (Pharmaceutical & Biotechnology), and Region - Global Forecast to 2030", chromatography resin market size was USD 3.02 billion in 2024 and is projected to reach USD 4.94 billion by 2030, at a CAGR of 8.6%, between 2025 and 2030. Browse in-depth TOC on "Chromatography Resin Market" 150 - Tables63 - Figures200 - Pages Download PDF Brochure: The use of chromatography resins is becoming popular due to their critical importance in the separation and purification of different industries, with biopharmaceuticals being the key industry. There is a growing need for high-purity biologics and stringent regulatory measures, and with this, manufacturers are turning towards sophisticated chromatography methods to produce products of good quality and safety. Since the pharmaceutical industry continues to grow and also aims at monoclonal antibodies, vaccines, and biosimilars, dependence on high-performance resins has escalated. The purification is performed accurately using these resins, and the process becomes efficient, and production time is minimized, which is significant in large-scale production. Rising investment in R&D and urging change toward continuous processing are also contributing to the demand for specialized and customized chromatography resins. Food testing, environmental monitoring, and academic research are also on the increase in the global market, enhancing the market. To satisfy changing requirements, companies are innovating products that offer resins with a greater degree of selectivity, binding capacities, and reusability. As bioprocessing and personalized medicine continue to grow, the market for chromatography resins is projected to strengthen and grow steadily in the forecast period. The synthetic resin type accounted for the second-largest share in terms of value, of the global chromatography resin market, in 2024. Synthetic resins accounted for the second-highest share of the chromatography resin market in 2024, due to its high mechanical strength, chemical stability, and capability to work in harsh conditions. These resins are employed at an industrial scale, particularly in the pharmaceutical and biotechnology industries, and their stability and extended service life have ensured uniform performance in the field as opposed to the natural resins. They have specific binding properties on their surface, which can be selected, enabling better separation of complex purification products like monoclonal antibodies and recombinant proteins. Also, synthetic resins have a wide solvent compatibility (and pH) profile, a factor that makes them useful in most chromatography methods. As there is an increasing need for effective and scalable purification technology, the usage of synthetic resins is likely to continue at a steady pace throughout the forecast period. Request Sample Pages: Food & beverage was the second-largest segment of the chromatography resin market, in terms of value, in 2024. The food & beverage application accounted for the second-largest share of the chromatography resin market due to the increasing product quality, safety, and regulatory independence. Chromatography resins are used in the determination and quantification of contaminants, pesticide product residues, preservatives, toxins, and other trace-level impurities that may influence the health of the consumer. As world food trade has grown and more focus on food safety has been offered by food safety regulatory bodies such as the FDA and EFSA, food manufacturers are increasingly taking the help of sophisticated chromatographic methods to comply with international food safety regulations. The use of these resins is also important in the study of nutritional value, flavoring compounds, coloring, and sweeteners, so the consistency of the products and their authenticity can be examined. Moreover, the growth in the processed food & beverages packaged industry and the nutraceutical industry has raised the demand for effective and efficient quality control instruments. Demand in the food & beverage industry is expected to continue increasing in the future as consumer awareness of food safety keeps increasing. Europe was the third-largest region in the global chromatography resin market in terms of value, in 2024. Europe holds the third largest share in the chromatography resin market because it has advanced pharmaceutical, biotechnology, and food industries, along with a well-established research infrastructure. The region features many leading biopharma companies and contract manufacturing organizations (CMOs) that heavily rely on chromatography as a key process for purifying biologics, monoclonal antibodies, and vaccines. Additionally, strict regulations from the European Medicines Agency (EMA) and other regional authorities require the use of advanced analytical methods, which drives the increasing demand for chromatography resins. Europe also emphasizes food safety, environmental monitoring, and uses chromatography primarily to detect contaminants and ensure quality. The development of chromatographic technologies is supported by funding from academic research centers and government-sponsored projects. Although North America and Asia-Pacific hold larger shares of the chromatography resin market in terms of volume and growth, Europe is a mature market focused on quality and regulatory compliance, solidifying its position in the global chromatography resin market. Request Customization: Key Players The key players profiled in the report include Bio-Rad Laboratories, Inc. (US), Merck KgaA (Germany), Danaher Corporation (US), Tosoh Corporation (Japan), Sartorius Stedim Biotech S.A. (France), Bio-Works Technologies AB (Sweden), Avantor, Inc. (US), Purolite (US), Repligen Corporation (US), Mitsubishi Chemical Group Corporation (Japan), and Thermo Fisher Scientific Inc. (US), among others. Get access to the latest updates on Chromatography Resin Companies and Chromatography Resin Market Size Browse Adjacent Market: Resins and Polymers Market Research Reports & Consulting Related Reports: Unsaturated Polyester Resin Market - Global Forecast to 2029 Ammonia Market - Global Forecast to 2029 Urea Market - Global Forecast to 2029 Methanol Market - Global Forecast to 2030 Solvents Market - Global Forecast to 2029 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio
Washington Post
16 minutes ago
- Washington Post
Live updates: Most higher tariff rates to take effect in a week, Trump administration says
Most of President Donald Trump's long-awaited and much-delayed 'reciprocal' tariffs, which were scheduled to kick in Friday, won't take effect for another week to give Customs and Border Protection officials time to prepare, the administration said late Thursday. Trump has rolled out frameworks for deals with 11 of the United States' top 15 trading partners. Temporary trade truces with China and Mexico will remain in effect as negotiators continue talks. But tariffs on other countries will soon escalate, barring late-hour deals. Trump has no public events scheduled Friday. He is heading to his golf club in Bedminster, New Jersey, for the weekend. After a rough start, President Donald Trump's campaign to reshape global trade suddenly seems to be advancing from strength to strength. Former vice president Kamala Harris expressed deep concern about U.S. democracy, describing it as a broken system on CBS's 'The Late Show With Stephen Colbert' on Thursday evening, in her first interview since the 2024 presidential election. President Donald Trump on Thursday finalized his long-awaited and much-delayed 'reciprocal' tariffs in a move designed to rebalance a global trading system that he argues has been tilted against the world's largest economy. In a pair of executive orders, the president increased tariffs on merchandise from about 70 countries and raised the rate on products made in Canada, one of the United States' largest trading partners, to a punitive 35 percent. The Trump administration on Thursday said it will send senior U.S. officials into war-ravaged Gaza to inspect food distribution sites and develop a plan to ensure more aid gets to civilians amid growing international anger over mass starvation there. Special envoy Steve Witkoff and U.S. Ambassador to Israel Mike Huckabee will travel inside the Palestinian enclave on Friday to hear 'firsthand about this dire situation,' White House press secretary Karoline Leavitt told reporters.
